Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant

Clinical trial NCT05305040 · TERMINATED

Trial details

NCT number: NCT05305040
Sponsor: AlloVir
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Adenovirus Infection BK Virus Infection Cytomegalovirus Infections Epstein-Barr Virus Infections Human Herpes Virus-6 Infection JC Virus Infection

Start date: 2022-03-24
Primary completion: 2024-01-30
Enrollment: 451

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.